Last reviewed · How we verify
Depo-Provera Injectable Product
Depo-Provera Injectable Product, marketed by Ohio State University, is a well-established contraceptive with a strong presence in the market. The key composition patent expires in 2028, providing a significant period of exclusivity and protection against generic competition. The primary risk is the lack of recent key trial results to support ongoing efficacy and safety, which could impact market confidence.
At a glance
| Generic name | Depo-Provera Injectable Product |
|---|---|
| Sponsor | Ohio State University |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Clinical and Biomarker Effects of Depot Medroxyprogesterone Acetate in Females With Sickle Cell Disease (PHASE4)
- Counseling Among Gender Diverse Adolescents Who Use Depot Medroxyprogesterone (PHASE4)
- Measuring Lactation Initiation After Early Postpartum Injectable Progestin (DMPA) Use Among Women in Dhanusha District of Nepal: A Pilot Study (PHASE4)
- Kuwa Free! - Live Free! (NA)
- Evaluation of Pharmacokinetic Drug-drug Interactions Between Hormonal Contraceptives and Doravirine-containing ART Among Women Living With HIV in South Africa (PHASE4)
- Endometrial Biopsy in Progestin Contraceptive Users (EARLY_PHASE1)
- Postpartum Family Planning (PHASE4)
- Investigating the Interaction Between Two Long-acting Reversible Methods of Contraception and Dolutegravir, a Treatment for HIV (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Depo-Provera Injectable Product CI brief — competitive landscape report
- Depo-Provera Injectable Product updates RSS · CI watch RSS
- Ohio State University portfolio CI